Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Rilmenidine manufacturers

1 products found

Filters

1 products found

rilmenidine

Tablets 1mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
France , Czech Republic , Austria , Slovakia , Estonia , Latvia , Lithuania , Bulgaria , Romania , Hungary , Portugal
Registered in
France , Austria , Czech Republic , Slovakia , Hungary , Latvia , Lithuania , Estonia , Bulgaria , Romania , Portugal
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #7903
A pharmaceutical manufacturer based in the EU that is active in 110+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 30+ years. Key production lines are Rx, OTC, nutraceuticals, medical devices, and veterinary. The company regulatory team prepares a CTD format dossier. The company possesses 10+ manufacturing plants in the EU and NA.

Manufacturer usually replies in 5 days

Rilmenidine

Rilmenidine is the first antihypertensive, with selectivity for I1 imidazoline receptors. It exerts effects both centrally by reducing sympathetic overactivity and in the kidney by inhibiting the Na+/H+ antiport. It is a recommended first-line treatment for mild-to-moderate essential hypertension. It is similar to other BP medicines in both the short and medium-term effects but has better long-term effects on cardiovascular morbidity and mortality. Studies have shown that it has long-term benefits similar to diuretics and β-blockers, ACE inhibitors, and calcium channel blockers. Rilmenidine is sold under the brand names Albarel, Hyperium, Iterium, and Tenaxum among others. Teva pharmaceuticals were first launched Rilmenidine in 1999 in Hungary and the Czech Republic and later approved by the Russian federation in 2004.

Dosage and administration

Rilmenidine is sold as tablets for oral use. In the treatment of Hypertension, the usual recommended adult dose is 1 mg, taken daily. The dose can be increased to 2mg a day after 1 month, given in divided doses, 1 tablet morning and evening before meals. Rilmenidine can be used by both elderly and diabetic hypertensive patients. If treating patients for hypertension with kidney failure, dosage adjustment is not needed if the creatinine clearance is greater than 15 mL/min. this medicine is taken for an indefinite period of time.

The Price of Rilmenidine

In the international market, a supply of 5mg costs USD122. In Latvia, the consumers have to pay an average price of $7.78 for a supply of 30 tablets of 1mg strength.

How does it work?

Rilmenidine exerts its antihypertensive effect by lowering the total peripheral resistance, mediated by a reduction in sympathetic activity. As a Central sympatholytics, it has a variety of antihypertensive actions, that increase sodium excretion and decrease the cardiac output, heart rate, total peripheral resistance, and renin release. It crosses the blood-brain barrier and stimulates the imidazoline I1 receptors and or central postsynaptic alpha2 adrenoceptors in the brainstem’s sympathetic nervous control centers.

Finding Rilmenidine Manufacturers and Suppliers:

The process of finding trusted Rilmenidine manufacturers and Rilmenidine suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B the marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. In addition, it is an easy-to-use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Rilmenidine. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.